Nuclear envelope dynamics

The nuclear envelope (NE) is the double lipid bilayer that encloses the genome, ensuring nucleocytoplasmic compartmentalization and spatial organization of cellular processes, regulating signal transduction and chromatin functionalization. Rather than being a static entity, the nuclear envelope rapidly changes its shape and integrity, its composition and associated proteome in response to extracellular and intracellular cues, triggering a variety of signalling cascades. Whereas it is clear that the nuclear envelope plays critical roles in ensuring cell fitness, we are only just beginning to understand the many dynamic processes that are orchestrated by the nuclear envelope.

Image may contain: Line.

Main research question

The Nuclear envelope dynamics project aims to characterize the pathways triggered by changes in NE topology, and to understand how these pathways affect cell fitness and fate. To address this, we focus on

  • The mechanistic regulation of NE integrity during cell division, interphase, and in micronuclei.
  • The effects of compromised of NE integrity on genome integrity, cell fitness and fate.
  • The consequences of nuclear lamina defects for NE functionalization and nuclear integrity during adipocyte differentiation.
  • The response of the NE to mechanical strain.

To address these questions, we use mechanistic cell biological studies that revolve around live-cell microscopy, proteomics, and genetics approaches in non-transformed cell lines, cancer cell lines, as well as primary cell models.

 

Movie: Cells undergo transient loss of nuclear integrity, as monitored by leakage of a nuclear fluorescent marker into the cytosol (in red, mCherry-NLS). These ruptures are accompanied by transient recruitment of the membrane repair machinery to the sites of rupture (in green, CHMP4B-mNG) resulting in restoration of nuclear integrity as evidenced by nuclear re-accumulation of mCherry-NLS.

Recent findings

Funding

  • The Research Council of Norway
  • South-East Norway Regional Health Authorities
  • The University of Oslo

Collaborations

  • Nolwenn Briand and Philippe Collas, Department of Molecular Medicine, Institute of Basic Medicine, University of Oslo, Oslo, Norway
  • Marina Vietri and Harald Stenmark, Institute for Cancer Research, The Norwegian Radium Hospital, Norway
  • Sebastian Schultz and Andreas Brech, Institute for Cancer Research, The Norwegian Radium Hospital, Norway
  • Roland Knorr, Max Plank Institute of Colloids and Interfaces, Department of Theory & Bio-Systems, Potsdam, Germany
  • Francesca Micci, Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway
  • Halim Kusumaatmaja, Department of Physics, Durham University, Durham, UK
  • Sushma Grellscheid, Computational Biology Unit, Department of Biological Sciences, University of Bergen, Bergen, Norway
Published Dec. 5, 2019 7:55 PM - Last modified Dec. 11, 2019 12:00 PM

Contact

Coen Campsteijn

Mailing address
P.O.Box 1112 Blindern
0317 Oslo

Visiting address
Domus Medica, Gaustad
Sognsvannsveien 9
0372 Oslo